- Home
- NXT vs ASND Comparison
NXT vs ASND Comparison
Compare NXT & ASND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NXT | ASND |
|---|---|---|
| Founded | 2013 | 2006 |
| Country | United States | Denmark |
| Employees | N/A | N/A |
| Industry | Semiconductors | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.2B | 13.2B |
| IPO Year | 2023 | 2015 |
Fundamental Metrics
Financial Performance| Metric | NXT | ASND |
|---|---|---|
| Price | $105.23 | $228.03 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 20 | 16 |
| Target Price | $94.42 | ★ $264.13 |
| AVG Volume (30 Days) | ★ 1.6M | 557.2K |
| Earning Date | 01-27-2026 | 02-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 3.85 | N/A |
| Revenue | ★ $3,373,226,000.00 | $758,592,045.00 |
| Revenue This Year | $17.63 | $99.54 |
| Revenue Next Year | $11.52 | $84.40 |
| P/E Ratio | $26.04 | ★ N/A |
| Revenue Growth | 20.37 | ★ 97.46 |
| 52 Week Low | $36.06 | $118.03 |
| 52 Week High | $112.74 | $229.94 |
Technical Indicators
Market Signals| Indicator | NXT | ASND |
|---|---|---|
| Relative Strength Index (RSI) | 65.32 | 62.13 |
| Support Level | $92.46 | $200.69 |
| Resistance Level | $100.94 | $221.75 |
| Average True Range (ATR) | 5.18 | 12.01 |
| MACD | 1.18 | 1.12 |
| Stochastic Oscillator | 95.32 | 80.19 |
Price Performance
Historical ComparisonAbout NXT Nextracker Inc.
Nextracker (and its subsidiaries) is a leading provider of intelligent, integrated solar tracker and software solutions used in utility-scale and distributed generation solar projects around the world. Nextracker's products enable solar panels in utility-scale power plants to follow the sun's movement across the sky and optimize plant performance. Nextracker has operations in the United States, Mexico, Spain and other countries in Europe, India, Australia, the Middle East, Africa, and Brazil.
About ASND Ascendis Pharma A/S
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology which includes TransCon PTH, TransCon CNP, and others. It operates in North America, Europe, and Rest of the world and derives the majority of its revenue from North America.